Any effect that assisted reproduction technology has on babies’ genes is largely corrected by adulthood, new research led by the Murdoch Children’s Research Institute has found.

Published in the latest edition of Nature Communications, the study* found events that occur in early development, including ovarian stimulation, manipulation of the embryo and the extra hormones common in fertility treatment cycles, can impact gene health or epigenetics but these effects are short lived.

Epigenetics is a process that controls how genes are turned on and off. Diet and other external environmental influences can play a role in this gene expression.

The study was designed to see how often epigenetic changes occur due to assisted reproduction technology and whether there were any differences in these changes from birth to adulthood.

“In two independent groups, we found the same effects of assisted reproduction on genes when examining heel prick blood spots collected soon after birth,” study senior MCRI Professor Richard Saffery says. “These epigenetic changes were not evident in the adult blood samples.”

MCRI Professor Jane Halliday, who established the cohort, and has studied the health of these individuals in adulthood, said assisted conception is linked to a small increased risk of preterm birth, low birth weight, being small for gestational age or perinatal mortality.

“Given the interventions associated with assisted reproduction technology at the time of conception, there were concerns that epigenetic changes may be taking place, silencing important genes and resulting in a heightened risk of health problems,” she says.

More than seven million people around the world, including more than 200,000 people in Australia have been conceived through assisted reproduction technology since 1978.

Dr Boris Novakovic, who performed most of the analysis for the study, says that despite the expansion of assisted reproduction technology worldwide, few studies have investigated the potential underlying effects on genes.

“Previous studies have found some epigenetic changes in embryos grown in labs. However, no study has looked for these changes in the same individuals at birth and adulthood as we have done,” he says.

“Our results are reassuring for families as they suggest that environment and lifestyle experienced from birth can repair any epigenetic deviations associated with fertility treatments.”

The study looked at a cohort of 158 Australians aged 22-35 years conceived through assisted reproduction technology (IVF and GIFT**) and 75 people conceived naturally.

Dr Novakovic says more studies of larger sample sizes are needed in order to replicate the current findings.

Researchers from the University of Melbourne, Monash University, University of Turku, Turku University Hospital, Victorian Assisted Reproductive Treatment Authority, The Royal Women’s Hospital, The Royal Children’s Hospital, Hudson Institute of Medical Research, and the Monash IVF Group also contributed to the findings.

*Publication: Boris Novakovic, Sharon Lewis, Jane Halliday, Joanne Kennedy, David P Burgner, Anne Czajko, B Kim, Alex Sexton-Oates, Markus Juonala, Karin Hammarberg, David J Amor, Lex W Doyle, Sarah Ranganathan, Liam Welsh, Michael Cheung, John McBain, Robert McLachlan and Richard Saffery. ‘Assisted reproductive technologies induce limited epigenetic variation at birth that largely resolves by adulthood’, Nature Communications.

**80 per cent of participants were born using IVF and 20 per cent using GIFT. GIFT involves removing a woman’s eggs, mixing them with sperm, and immediately placing them into a fallopian tube, unlike IVF where the fertilised egg is grown in a lab for a few days before being transferred to the womb.

Available for interview:

Professor Richard Saffery

Dr Boris Novakovic

Professor Jane Halliday

Professor Robert McLachlan (Monash IVF/ Hudson Institute of Medical Research)

Case study

Media Contacts:

Bridie Byrne

MCRI communications specialist

+613 9936 6211 / 0403 664 416

bridie.byrne@mcri.edu.au

The study was funded by a National Health & Medical Research Council Project Grant (APP1099641; 2016–2017), The Royal Children’s Hospital Research Foundation, Monash IVF Research and Education Foundation, and Reproductive Biology Unit Sperm Fund, Melbourne IVF. BN is supported by an NHMRC (Australia) CJ Martin Fellowship (1072966). DPB is supported by an NHMRC Senior Research Fellowship (1064629).